Navigation Links
Experimental treatments restore partial vision to blind people
Date:10/20/2009

Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments.

The new studies tested both people and animals with two degenerative eye diseases: retinitis pigmentosa and age-related macular degeneration. These diseases destroy the light-sensitive nerve cells in the retina, leading to blindness. In all, vision loss and eye disease affect 3.6 million Americans and cost the United States $68 billion each year.

Research released today shows that:

  • A retinal prosthesis restores partial vision to people who are totally blind. The prosthesis, made of an array of electrodes, transmits visual information captured by a video camera (Jessy Dorn, PhD, abstract 216.6, see attached summary).

  • Transplanted "sheets" of fetal retinal cells improve visual acuity in several people with retinitis pigmentosa and age-related macular degeneration (Robert B. Aramant, PhD, abstract 837.12, see attached summary).

  • Engineered, light-sensitive proteins restore vision in a mouse study of retinitis pigmentosa. The findings could lead to new treatments for people with degenerative retinal diseases (Natalia Caporale, PhD, abstract 806.10, see attached summary).

  • As researchers strive to develop stem cell therapies for eye disease, a new method increases the yield of retinal cells from human stem cells derived from both embryonic and adult tissue (Jason S. Meyer, PhD, abstract 113.1, see attached summary).

"Basic neuroscience research has formed the basis for significant progress in treating eye disease," said press conference moderator Rachel O. L. Wong, PhD, of the University of Washington, an expert on visual system development. "These studies would not be possible without technological advances and basic science research that continues to explain the normal function and development of the visual system," Wong said.


'/>"/>

Contact: Kat Snodgrass
ksnodgrass@sfn.org
202-299-7957
Society for Neuroscience
Source:Eurekalert

Related biology news :

1. Experimental Biology 2008 meets in San Diego April 5-9
2. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
3. Experimental Biology and Medicine announces expansion into Asia, opens new office
4. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
5. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize
6. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
7. 40 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans
8. Experimental treatment halts hypoxic-ischemic brain injury in newborns
9. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
10. Paradigm shift in Alzheimerss research: new treatments
11. NIH selects LIAI for major study on allergy molecular causes and possible treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... DALLAS , Nov. 18, 2016 Securus ... technology solutions for public safety, investigation, corrections and monitoring, ... a smaller competitor, ICSolutions, to have an independent technology ... set, the most modern high tech/sophisticated telephone calling platform, ... tell customers that they do most of what we ...
(Date:11/15/2016)... 15, 2016  Synthetic Biologics, Inc. (NYSE MKT: ... on the gut microbiome, today announced the pricing ... of its common stock and warrants to purchase ... price to the public of $1.00 per share ... from the offering, excluding the proceeds, if any ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... offering. The report forecasts the ... at a CAGR of 12.28% during the period 2016-2020. ... analysis with inputs from industry experts. The report covers the market ... also includes a discussion of the key vendors operating in this ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... BELLINGHAM, Washington, USA (PRWEB) , ... December 02, ... ... the role of innovative U.S.-owned and -operated small businesses in federally funded research ... SPIE, the international society for optics and photonics . , As part ...
(Date:12/2/2016)... 2, 2016 More than $4.3 million was raised ... ( DHMD ). The gala was held at the American ... City and honored Alan Alda and ... health and medicine and the public understanding of science. Since ... the event has raised $40 million for the Laboratory,s research ...
(Date:12/2/2016)... ... ... ACEA Biosciences, Inc. announced today that it will be presenting updated efficacy ... Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. , ... AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M resistance ...
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
Breaking Biology Technology: